nodes	percent_of_prediction	percent_of_DWPC	metapath
Alendronate—PTPRE—portal vein—pancreatic cancer	0.275	0.782	CbGeAlD
Alendronate—PTPN4—digestive system—pancreatic cancer	0.0177	0.0503	CbGeAlD
Alendronate—ATP6V1A—islet of Langerhans—pancreatic cancer	0.0145	0.0414	CbGeAlD
Alendronate—FDPS—islet of Langerhans—pancreatic cancer	0.011	0.0312	CbGeAlD
Alendronate—ATP6V1A—pancreas—pancreatic cancer	0.0102	0.0291	CbGeAlD
Alendronate—ATP6V1A—digestive system—pancreatic cancer	0.00873	0.0249	CbGeAlD
Alendronate—PTPRE—IL6-mediated signaling events—BCL2L1—pancreatic cancer	0.00778	0.104	CbGpPWpGaD
Alendronate—FDPS—pancreas—pancreatic cancer	0.0077	0.0219	CbGeAlD
Alendronate—FDPS—digestive system—pancreatic cancer	0.00658	0.0187	CbGeAlD
Alendronate—PTPRS—Extracellular matrix organization—EFEMP1—pancreatic cancer	0.00468	0.0628	CbGpPWpGaD
Alendronate—PTPRE—IL6-mediated signaling events—STAT3—pancreatic cancer	0.00405	0.0542	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—PRSS1—pancreatic cancer	0.00392	0.0526	CbGpPWpGaD
Alendronate—PTPRE—IL6-mediated signaling events—MYC—pancreatic cancer	0.00376	0.0504	CbGpPWpGaD
Alendronate—PTPRE—IL6-mediated signaling events—PIK3CA—pancreatic cancer	0.00319	0.0428	CbGpPWpGaD
Alendronate—Risedronate—PTGS2—pancreatic cancer	0.00314	0.529	CrCbGaD
Alendronate—Clodronate—PTGS2—pancreatic cancer	0.0028	0.471	CrCbGaD
Alendronate—PTPRE—IL6-mediated signaling events—AKT1—pancreatic cancer	0.00261	0.035	CbGpPWpGaD
Alendronate—PTPRS—ECM proteoglycans—TGFB1—pancreatic cancer	0.0019	0.0255	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00183	0.0245	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—CD44—pancreatic cancer	0.00173	0.0232	CbGpPWpGaD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.00149	0.02	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling by Insulin receptor—STK11—pancreatic cancer	0.00147	0.0198	CbGpPWpGaD
Alendronate—Chest pain—Sunitinib—pancreatic cancer	0.00125	0.00219	CcSEcCtD
Alendronate—Myalgia—Sunitinib—pancreatic cancer	0.00125	0.00219	CcSEcCtD
Alendronate—Dyspepsia—Tamoxifen—pancreatic cancer	0.00123	0.00216	CcSEcCtD
Alendronate—Alopecia—Irinotecan—pancreatic cancer	0.00123	0.00216	CcSEcCtD
Alendronate—Dyspepsia—Erlotinib—pancreatic cancer	0.00122	0.00214	CcSEcCtD
Alendronate—Musculoskeletal pain—Doxorubicin—pancreatic cancer	0.00121	0.00212	CcSEcCtD
Alendronate—Dysphagia—Docetaxel—pancreatic cancer	0.0012	0.00211	CcSEcCtD
Alendronate—Constipation—Tamoxifen—pancreatic cancer	0.00119	0.0021	CcSEcCtD
Alendronate—Pain—Tamoxifen—pancreatic cancer	0.00119	0.0021	CcSEcCtD
Alendronate—Alopecia—Gemcitabine—pancreatic cancer	0.00119	0.0021	CcSEcCtD
Alendronate—Flatulence—Irinotecan—pancreatic cancer	0.00119	0.00209	CcSEcCtD
Alendronate—Infection—Sunitinib—pancreatic cancer	0.00119	0.00209	CcSEcCtD
Alendronate—Constipation—Erlotinib—pancreatic cancer	0.00118	0.00208	CcSEcCtD
Alendronate—Pain—Erlotinib—pancreatic cancer	0.00118	0.00208	CcSEcCtD
Alendronate—Oesophagitis—Epirubicin—pancreatic cancer	0.00118	0.00207	CcSEcCtD
Alendronate—Erythema—Gemcitabine—pancreatic cancer	0.00118	0.00207	CcSEcCtD
Alendronate—Alopecia—Fluorouracil—pancreatic cancer	0.00117	0.00206	CcSEcCtD
Alendronate—Melaena—Doxorubicin—pancreatic cancer	0.00116	0.00205	CcSEcCtD
Alendronate—Muscle spasms—Irinotecan—pancreatic cancer	0.00116	0.00204	CcSEcCtD
Alendronate—Influenza like illness—Doxorubicin—pancreatic cancer	0.00116	0.00204	CcSEcCtD
Alendronate—Erythema—Fluorouracil—pancreatic cancer	0.00116	0.00203	CcSEcCtD
Alendronate—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00114	0.00201	CcSEcCtD
Alendronate—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.00113	0.00199	CcSEcCtD
Alendronate—Ill-defined disorder—Irinotecan—pancreatic cancer	0.00112	0.00197	CcSEcCtD
Alendronate—Anaemia—Irinotecan—pancreatic cancer	0.00112	0.00196	CcSEcCtD
Alendronate—Urticaria—Tamoxifen—pancreatic cancer	0.00111	0.00195	CcSEcCtD
Alendronate—Abdominal pain—Tamoxifen—pancreatic cancer	0.0011	0.00194	CcSEcCtD
Alendronate—Abdominal pain—Erlotinib—pancreatic cancer	0.00109	0.00192	CcSEcCtD
Alendronate—Body temperature increased—Erlotinib—pancreatic cancer	0.00109	0.00192	CcSEcCtD
Alendronate—Ill-defined disorder—Gemcitabine—pancreatic cancer	0.00109	0.00192	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.00109	0.00192	CcSEcCtD
Alendronate—Malaise—Irinotecan—pancreatic cancer	0.00109	0.00191	CcSEcCtD
Alendronate—Oesophagitis—Doxorubicin—pancreatic cancer	0.00109	0.00191	CcSEcCtD
Alendronate—FDPS—SREBP signalling—PPARG—pancreatic cancer	0.00109	0.0146	CbGpPWpGaD
Alendronate—Anaemia—Gemcitabine—pancreatic cancer	0.00109	0.00191	CcSEcCtD
Alendronate—Vertigo—Irinotecan—pancreatic cancer	0.00108	0.00191	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—KDR—pancreatic cancer	0.00107	0.0144	CbGpPWpGaD
Alendronate—Anaemia—Fluorouracil—pancreatic cancer	0.00107	0.00188	CcSEcCtD
Alendronate—Photosensitivity—Epirubicin—pancreatic cancer	0.00106	0.00187	CcSEcCtD
Alendronate—Malaise—Gemcitabine—pancreatic cancer	0.00106	0.00187	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.00106	0.00186	CcSEcCtD
Alendronate—ATP6V1A—Signaling by Insulin receptor—TSC2—pancreatic cancer	0.00105	0.0141	CbGpPWpGaD
Alendronate—Dyspepsia—Sunitinib—pancreatic cancer	0.00105	0.00185	CcSEcCtD
Alendronate—Stomatitis—Docetaxel—pancreatic cancer	0.00104	0.00183	CcSEcCtD
Alendronate—Hypersensitivity—Tamoxifen—pancreatic cancer	0.00103	0.00181	CcSEcCtD
Alendronate—Pain—Sunitinib—pancreatic cancer	0.00102	0.0018	CcSEcCtD
Alendronate—Constipation—Sunitinib—pancreatic cancer	0.00102	0.0018	CcSEcCtD
Alendronate—Discomfort—Irinotecan—pancreatic cancer	0.00102	0.00179	CcSEcCtD
Alendronate—Asthenia—Tamoxifen—pancreatic cancer	0.001	0.00176	CcSEcCtD
Alendronate—Chest pain—Gemcitabine—pancreatic cancer	0.001	0.00176	CcSEcCtD
Alendronate—Myalgia—Gemcitabine—pancreatic cancer	0.001	0.00176	CcSEcCtD
Alendronate—Asthenia—Erlotinib—pancreatic cancer	0.000991	0.00174	CcSEcCtD
Alendronate—Discomfort—Gemcitabine—pancreatic cancer	0.000989	0.00174	CcSEcCtD
Alendronate—Pruritus—Tamoxifen—pancreatic cancer	0.000988	0.00174	CcSEcCtD
Alendronate—Photosensitivity—Doxorubicin—pancreatic cancer	0.000985	0.00173	CcSEcCtD
Alendronate—Chest pain—Fluorouracil—pancreatic cancer	0.000984	0.00173	CcSEcCtD
Alendronate—Myalgia—Fluorouracil—pancreatic cancer	0.000984	0.00173	CcSEcCtD
Alendronate—Infection—Irinotecan—pancreatic cancer	0.000979	0.00172	CcSEcCtD
Alendronate—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000978	0.00172	CcSEcCtD
Alendronate—Pruritus—Erlotinib—pancreatic cancer	0.000977	0.00172	CcSEcCtD
Alendronate—Discomfort—Fluorouracil—pancreatic cancer	0.000972	0.00171	CcSEcCtD
Alendronate—Haemoglobin—Docetaxel—pancreatic cancer	0.000963	0.00169	CcSEcCtD
Alendronate—Haemorrhage—Docetaxel—pancreatic cancer	0.000958	0.00169	CcSEcCtD
Alendronate—Diarrhoea—Tamoxifen—pancreatic cancer	0.000955	0.00168	CcSEcCtD
Alendronate—Infection—Gemcitabine—pancreatic cancer	0.000953	0.00168	CcSEcCtD
Alendronate—Body temperature increased—Sunitinib—pancreatic cancer	0.000945	0.00166	CcSEcCtD
Alendronate—Abdominal pain—Sunitinib—pancreatic cancer	0.000945	0.00166	CcSEcCtD
Alendronate—Diarrhoea—Erlotinib—pancreatic cancer	0.000945	0.00166	CcSEcCtD
Alendronate—Oedema peripheral—Docetaxel—pancreatic cancer	0.000944	0.00166	CcSEcCtD
Alendronate—Infection—Fluorouracil—pancreatic cancer	0.000937	0.00165	CcSEcCtD
Alendronate—Dizziness—Tamoxifen—pancreatic cancer	0.000923	0.00162	CcSEcCtD
Alendronate—Dizziness—Erlotinib—pancreatic cancer	0.000913	0.00161	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—CDH1—pancreatic cancer	0.000908	0.0122	CbGpPWpGaD
Alendronate—Erythema multiforme—Docetaxel—pancreatic cancer	0.000906	0.00159	CcSEcCtD
Alendronate—Vomiting—Tamoxifen—pancreatic cancer	0.000888	0.00156	CcSEcCtD
Alendronate—Hypersensitivity—Sunitinib—pancreatic cancer	0.000881	0.00155	CcSEcCtD
Alendronate—Rash—Tamoxifen—pancreatic cancer	0.00088	0.00155	CcSEcCtD
Alendronate—Dermatitis—Tamoxifen—pancreatic cancer	0.00088	0.00155	CcSEcCtD
Alendronate—Vomiting—Erlotinib—pancreatic cancer	0.000878	0.00155	CcSEcCtD
Alendronate—Headache—Tamoxifen—pancreatic cancer	0.000875	0.00154	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000874	0.00154	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—MMP2—pancreatic cancer	0.000874	0.0117	CbGpPWpGaD
Alendronate—Rash—Erlotinib—pancreatic cancer	0.000871	0.00153	CcSEcCtD
Alendronate—Dermatitis—Erlotinib—pancreatic cancer	0.00087	0.00153	CcSEcCtD
Alendronate—Dyspepsia—Irinotecan—pancreatic cancer	0.000867	0.00153	CcSEcCtD
Alendronate—Headache—Erlotinib—pancreatic cancer	0.000865	0.00152	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.00086	0.00151	CcSEcCtD
Alendronate—Asthenia—Sunitinib—pancreatic cancer	0.000858	0.00151	CcSEcCtD
Alendronate—Dry skin—Epirubicin—pancreatic cancer	0.000857	0.00151	CcSEcCtD
Alendronate—Alopecia—Docetaxel—pancreatic cancer	0.000847	0.00149	CcSEcCtD
Alendronate—Pruritus—Sunitinib—pancreatic cancer	0.000846	0.00149	CcSEcCtD
Alendronate—Pain—Irinotecan—pancreatic cancer	0.000842	0.00148	CcSEcCtD
Alendronate—Constipation—Irinotecan—pancreatic cancer	0.000842	0.00148	CcSEcCtD
Alendronate—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000841	0.00148	CcSEcCtD
Alendronate—Erythema—Docetaxel—pancreatic cancer	0.000834	0.00147	CcSEcCtD
Alendronate—Dyspepsia—Fluorouracil—pancreatic cancer	0.00083	0.00146	CcSEcCtD
Alendronate—Nausea—Tamoxifen—pancreatic cancer	0.000829	0.00146	CcSEcCtD
Alendronate—Gastritis—Epirubicin—pancreatic cancer	0.000827	0.00145	CcSEcCtD
Alendronate—Pain—Gemcitabine—pancreatic cancer	0.000821	0.00144	CcSEcCtD
Alendronate—Constipation—Gemcitabine—pancreatic cancer	0.000821	0.00144	CcSEcCtD
Alendronate—Nausea—Erlotinib—pancreatic cancer	0.000821	0.00144	CcSEcCtD
Alendronate—Diarrhoea—Sunitinib—pancreatic cancer	0.000818	0.00144	CcSEcCtD
Alendronate—Dysgeusia—Docetaxel—pancreatic cancer	0.000817	0.00144	CcSEcCtD
Alendronate—Abdominal distension—Epirubicin—pancreatic cancer	0.000813	0.00143	CcSEcCtD
Alendronate—Feeling abnormal—Irinotecan—pancreatic cancer	0.000812	0.00143	CcSEcCtD
Alendronate—Asthma—Epirubicin—pancreatic cancer	0.000808	0.00142	CcSEcCtD
Alendronate—Dysphagia—Epirubicin—pancreatic cancer	0.000808	0.00142	CcSEcCtD
Alendronate—Pain—Fluorouracil—pancreatic cancer	0.000807	0.00142	CcSEcCtD
Alendronate—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000805	0.00142	CcSEcCtD
Alendronate—Muscle spasms—Docetaxel—pancreatic cancer	0.000802	0.00141	CcSEcCtD
Alendronate—Dry skin—Doxorubicin—pancreatic cancer	0.000793	0.00139	CcSEcCtD
Alendronate—Dizziness—Sunitinib—pancreatic cancer	0.000791	0.00139	CcSEcCtD
Alendronate—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000791	0.00139	CcSEcCtD
Alendronate—Body temperature increased—Irinotecan—pancreatic cancer	0.000779	0.00137	CcSEcCtD
Alendronate—Abdominal pain—Irinotecan—pancreatic cancer	0.000779	0.00137	CcSEcCtD
Alendronate—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000779	0.00137	CcSEcCtD
Alendronate—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000777	0.00137	CcSEcCtD
Alendronate—Anaemia—Docetaxel—pancreatic cancer	0.000771	0.00136	CcSEcCtD
Alendronate—Gastritis—Doxorubicin—pancreatic cancer	0.000765	0.00135	CcSEcCtD
Alendronate—Vomiting—Sunitinib—pancreatic cancer	0.00076	0.00134	CcSEcCtD
Alendronate—Body temperature increased—Gemcitabine—pancreatic cancer	0.000759	0.00133	CcSEcCtD
Alendronate—Rash—Sunitinib—pancreatic cancer	0.000754	0.00133	CcSEcCtD
Alendronate—Dermatitis—Sunitinib—pancreatic cancer	0.000753	0.00133	CcSEcCtD
Alendronate—Abdominal distension—Doxorubicin—pancreatic cancer	0.000752	0.00132	CcSEcCtD
Alendronate—Urticaria—Fluorouracil—pancreatic cancer	0.000749	0.00132	CcSEcCtD
Alendronate—Headache—Sunitinib—pancreatic cancer	0.000749	0.00132	CcSEcCtD
Alendronate—Dysphagia—Doxorubicin—pancreatic cancer	0.000747	0.00131	CcSEcCtD
Alendronate—Asthma—Doxorubicin—pancreatic cancer	0.000747	0.00131	CcSEcCtD
Alendronate—Body temperature increased—Fluorouracil—pancreatic cancer	0.000746	0.00131	CcSEcCtD
Alendronate—Photosensitivity reaction—Epirubicin—pancreatic cancer	0.000737	0.0013	CcSEcCtD
Alendronate—Hypersensitivity—Irinotecan—pancreatic cancer	0.000726	0.00128	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000714	0.00126	CcSEcCtD
Alendronate—ATP6V1A—Signaling by Insulin receptor—PIK3CB—pancreatic cancer	0.000713	0.00956	CbGpPWpGaD
Alendronate—Chest pain—Docetaxel—pancreatic cancer	0.00071	0.00125	CcSEcCtD
Alendronate—Myalgia—Docetaxel—pancreatic cancer	0.00071	0.00125	CcSEcCtD
Alendronate—Nausea—Sunitinib—pancreatic cancer	0.00071	0.00125	CcSEcCtD
Alendronate—Asthenia—Irinotecan—pancreatic cancer	0.000707	0.00124	CcSEcCtD
Alendronate—Stomatitis—Epirubicin—pancreatic cancer	0.000702	0.00123	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—CASP3—pancreatic cancer	0.000695	0.00932	CbGpPWpGaD
Alendronate—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000695	0.00122	CcSEcCtD
Alendronate—Asthenia—Gemcitabine—pancreatic cancer	0.000688	0.00121	CcSEcCtD
Alendronate—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000682	0.0012	CcSEcCtD
Alendronate—Pruritus—Gemcitabine—pancreatic cancer	0.000679	0.00119	CcSEcCtD
Alendronate—Infection—Docetaxel—pancreatic cancer	0.000676	0.00119	CcSEcCtD
Alendronate—Diarrhoea—Irinotecan—pancreatic cancer	0.000674	0.00119	CcSEcCtD
Alendronate—Pruritus—Fluorouracil—pancreatic cancer	0.000667	0.00117	CcSEcCtD
Alendronate—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000661	0.00116	CcSEcCtD
Alendronate—PTPRS—Extracellular matrix organization—MMP9—pancreatic cancer	0.000657	0.00881	CbGpPWpGaD
Alendronate—Diarrhoea—Gemcitabine—pancreatic cancer	0.000657	0.00116	CcSEcCtD
Alendronate—Dizziness—Irinotecan—pancreatic cancer	0.000651	0.00115	CcSEcCtD
Alendronate—Haemoglobin—Epirubicin—pancreatic cancer	0.00065	0.00114	CcSEcCtD
Alendronate—Stomatitis—Doxorubicin—pancreatic cancer	0.000649	0.00114	CcSEcCtD
Alendronate—Haemorrhage—Epirubicin—pancreatic cancer	0.000646	0.00114	CcSEcCtD
Alendronate—Diarrhoea—Fluorouracil—pancreatic cancer	0.000645	0.00114	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—GDI1—pancreatic cancer	0.000637	0.00855	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GDI2—pancreatic cancer	0.000637	0.00855	CbGpPWpGaD
Alendronate—Oedema peripheral—Epirubicin—pancreatic cancer	0.000637	0.00112	CcSEcCtD
Alendronate—Vomiting—Irinotecan—pancreatic cancer	0.000626	0.0011	CcSEcCtD
Alendronate—Dizziness—Fluorouracil—pancreatic cancer	0.000624	0.0011	CcSEcCtD
Alendronate—Rash—Irinotecan—pancreatic cancer	0.000621	0.00109	CcSEcCtD
Alendronate—Dermatitis—Irinotecan—pancreatic cancer	0.000621	0.00109	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.00062	0.00109	CcSEcCtD
Alendronate—Headache—Irinotecan—pancreatic cancer	0.000617	0.00109	CcSEcCtD
Alendronate—Erythema multiforme—Epirubicin—pancreatic cancer	0.000611	0.00108	CcSEcCtD
Alendronate—Vomiting—Gemcitabine—pancreatic cancer	0.00061	0.00107	CcSEcCtD
Alendronate—Rash—Gemcitabine—pancreatic cancer	0.000605	0.00106	CcSEcCtD
Alendronate—Dermatitis—Gemcitabine—pancreatic cancer	0.000604	0.00106	CcSEcCtD
Alendronate—Haemoglobin—Doxorubicin—pancreatic cancer	0.000601	0.00106	CcSEcCtD
Alendronate—Headache—Gemcitabine—pancreatic cancer	0.000601	0.00106	CcSEcCtD
Alendronate—Vomiting—Fluorouracil—pancreatic cancer	0.0006	0.00106	CcSEcCtD
Alendronate—Dyspepsia—Docetaxel—pancreatic cancer	0.000599	0.00105	CcSEcCtD
Alendronate—Haemorrhage—Doxorubicin—pancreatic cancer	0.000598	0.00105	CcSEcCtD
Alendronate—Rash—Fluorouracil—pancreatic cancer	0.000595	0.00105	CcSEcCtD
Alendronate—Dermatitis—Fluorouracil—pancreatic cancer	0.000594	0.00105	CcSEcCtD
Alendronate—Headache—Fluorouracil—pancreatic cancer	0.000591	0.00104	CcSEcCtD
Alendronate—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000589	0.00104	CcSEcCtD
Alendronate—Nausea—Irinotecan—pancreatic cancer	0.000585	0.00103	CcSEcCtD
Alendronate—Constipation—Docetaxel—pancreatic cancer	0.000582	0.00102	CcSEcCtD
Alendronate—Pain—Docetaxel—pancreatic cancer	0.000582	0.00102	CcSEcCtD
Alendronate—Alopecia—Epirubicin—pancreatic cancer	0.000571	0.00101	CcSEcCtD
Alendronate—Nausea—Gemcitabine—pancreatic cancer	0.00057	0.001	CcSEcCtD
Alendronate—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000566	0.000995	CcSEcCtD
Alendronate—Erythema—Epirubicin—pancreatic cancer	0.000563	0.00099	CcSEcCtD
Alendronate—ATP6V1A—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000562	0.00754	CbGpPWpGaD
Alendronate—Feeling abnormal—Docetaxel—pancreatic cancer	0.000561	0.000987	CcSEcCtD
Alendronate—Nausea—Fluorouracil—pancreatic cancer	0.00056	0.000986	CcSEcCtD
Alendronate—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000557	0.00098	CcSEcCtD
Alendronate—Flatulence—Epirubicin—pancreatic cancer	0.000555	0.000976	CcSEcCtD
Alendronate—ATP6V1A—Disease—ZNRF3—pancreatic cancer	0.000551	0.00739	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PRSS1—pancreatic cancer	0.000551	0.00739	CbGpPWpGaD
Alendronate—Dysgeusia—Epirubicin—pancreatic cancer	0.000551	0.00097	CcSEcCtD
Alendronate—ATP6V1A—Signaling by Insulin receptor—NRAS—pancreatic cancer	0.000549	0.00737	CbGpPWpGaD
Alendronate—PTPRS—Extracellular matrix organization—TGFB1—pancreatic cancer	0.000541	0.00726	CbGpPWpGaD
Alendronate—Muscle spasms—Epirubicin—pancreatic cancer	0.000541	0.000952	CcSEcCtD
Alendronate—Body temperature increased—Docetaxel—pancreatic cancer	0.000538	0.000947	CcSEcCtD
Alendronate—Abdominal pain—Docetaxel—pancreatic cancer	0.000538	0.000947	CcSEcCtD
Alendronate—Alopecia—Doxorubicin—pancreatic cancer	0.000529	0.00093	CcSEcCtD
Alendronate—FDPS—SREBP signalling—PIK3CA—pancreatic cancer	0.000526	0.00706	CbGpPWpGaD
Alendronate—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000522	0.000919	CcSEcCtD
Alendronate—Erythema—Doxorubicin—pancreatic cancer	0.000521	0.000916	CcSEcCtD
Alendronate—Anaemia—Epirubicin—pancreatic cancer	0.00052	0.000915	CcSEcCtD
Alendronate—Flatulence—Doxorubicin—pancreatic cancer	0.000513	0.000903	CcSEcCtD
Alendronate—Dysgeusia—Doxorubicin—pancreatic cancer	0.00051	0.000897	CcSEcCtD
Alendronate—Malaise—Epirubicin—pancreatic cancer	0.000507	0.000893	CcSEcCtD
Alendronate—Vertigo—Epirubicin—pancreatic cancer	0.000506	0.00089	CcSEcCtD
Alendronate—Hypersensitivity—Docetaxel—pancreatic cancer	0.000502	0.000883	CcSEcCtD
Alendronate—Muscle spasms—Doxorubicin—pancreatic cancer	0.000501	0.000881	CcSEcCtD
Alendronate—ATP6V1A—Disease—DTX1—pancreatic cancer	0.000499	0.00669	CbGpPWpGaD
Alendronate—Asthenia—Docetaxel—pancreatic cancer	0.000489	0.00086	CcSEcCtD
Alendronate—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000483	0.00085	CcSEcCtD
Alendronate—Pruritus—Docetaxel—pancreatic cancer	0.000482	0.000848	CcSEcCtD
Alendronate—Anaemia—Doxorubicin—pancreatic cancer	0.000481	0.000847	CcSEcCtD
Alendronate—Chest pain—Epirubicin—pancreatic cancer	0.000479	0.000843	CcSEcCtD
Alendronate—Myalgia—Epirubicin—pancreatic cancer	0.000479	0.000843	CcSEcCtD
Alendronate—Discomfort—Epirubicin—pancreatic cancer	0.000473	0.000833	CcSEcCtD
Alendronate—ATP6V1A—Signaling by Insulin receptor—KRAS—pancreatic cancer	0.000473	0.00634	CbGpPWpGaD
Alendronate—Malaise—Doxorubicin—pancreatic cancer	0.00047	0.000826	CcSEcCtD
Alendronate—Vertigo—Doxorubicin—pancreatic cancer	0.000468	0.000823	CcSEcCtD
Alendronate—Diarrhoea—Docetaxel—pancreatic cancer	0.000466	0.00082	CcSEcCtD
Alendronate—Infection—Epirubicin—pancreatic cancer	0.000456	0.000803	CcSEcCtD
Alendronate—Dizziness—Docetaxel—pancreatic cancer	0.00045	0.000792	CcSEcCtD
Alendronate—Chest pain—Doxorubicin—pancreatic cancer	0.000443	0.00078	CcSEcCtD
Alendronate—Myalgia—Doxorubicin—pancreatic cancer	0.000443	0.00078	CcSEcCtD
Alendronate—Discomfort—Doxorubicin—pancreatic cancer	0.000438	0.000771	CcSEcCtD
Alendronate—ATP6V1A—Signaling by Insulin receptor—PIK3CA—pancreatic cancer	0.000434	0.00583	CbGpPWpGaD
Alendronate—Vomiting—Docetaxel—pancreatic cancer	0.000433	0.000762	CcSEcCtD
Alendronate—FDPS—SREBP signalling—AKT1—pancreatic cancer	0.00043	0.00577	CbGpPWpGaD
Alendronate—Rash—Docetaxel—pancreatic cancer	0.000429	0.000755	CcSEcCtD
Alendronate—Dermatitis—Docetaxel—pancreatic cancer	0.000429	0.000755	CcSEcCtD
Alendronate—Headache—Docetaxel—pancreatic cancer	0.000427	0.00075	CcSEcCtD
Alendronate—Infection—Doxorubicin—pancreatic cancer	0.000422	0.000743	CcSEcCtD
Alendronate—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000418	0.000736	CcSEcCtD
Alendronate—ATP6V1A—Disease—DTX4—pancreatic cancer	0.000418	0.0056	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PRLHR—pancreatic cancer	0.000411	0.00551	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PPP2R5B—pancreatic cancer	0.000407	0.00545	CbGpPWpGaD
Alendronate—Nausea—Docetaxel—pancreatic cancer	0.000404	0.000712	CcSEcCtD
Alendronate—Dyspepsia—Epirubicin—pancreatic cancer	0.000404	0.000711	CcSEcCtD
Alendronate—ATP6V1A—Signaling by Insulin receptor—HRAS—pancreatic cancer	0.000402	0.00539	CbGpPWpGaD
Alendronate—Pain—Epirubicin—pancreatic cancer	0.000393	0.000691	CcSEcCtD
Alendronate—Constipation—Epirubicin—pancreatic cancer	0.000393	0.000691	CcSEcCtD
Alendronate—ATP6V1A—Disease—HEY2—pancreatic cancer	0.000391	0.00525	CbGpPWpGaD
Alendronate—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000387	0.000681	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—ZNRF3—pancreatic cancer	0.000386	0.00518	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—ACVR1B—pancreatic cancer	0.000386	0.00518	CbGpPWpGaD
Alendronate—Feeling abnormal—Epirubicin—pancreatic cancer	0.000378	0.000666	CcSEcCtD
Alendronate—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000376	0.000661	CcSEcCtD
Alendronate—Dyspepsia—Doxorubicin—pancreatic cancer	0.000374	0.000658	CcSEcCtD
Alendronate—FDPS—Metabolism—PRSS1—pancreatic cancer	0.000369	0.00495	CbGpPWpGaD
Alendronate—Urticaria—Epirubicin—pancreatic cancer	0.000365	0.000642	CcSEcCtD
Alendronate—Constipation—Doxorubicin—pancreatic cancer	0.000363	0.000639	CcSEcCtD
Alendronate—Pain—Doxorubicin—pancreatic cancer	0.000363	0.000639	CcSEcCtD
Alendronate—Body temperature increased—Epirubicin—pancreatic cancer	0.000363	0.000639	CcSEcCtD
Alendronate—Abdominal pain—Epirubicin—pancreatic cancer	0.000363	0.000639	CcSEcCtD
Alendronate—ATP6V1A—Disease—HEY1—pancreatic cancer	0.000362	0.00486	CbGpPWpGaD
Alendronate—Feeling abnormal—Doxorubicin—pancreatic cancer	0.00035	0.000616	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—DTX1—pancreatic cancer	0.000349	0.00468	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SSTR3—pancreatic cancer	0.000349	0.00468	CbGpPWpGaD
Alendronate—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000348	0.000611	CcSEcCtD
Alendronate—Hypersensitivity—Epirubicin—pancreatic cancer	0.000338	0.000595	CcSEcCtD
Alendronate—Urticaria—Doxorubicin—pancreatic cancer	0.000338	0.000594	CcSEcCtD
Alendronate—Body temperature increased—Doxorubicin—pancreatic cancer	0.000336	0.000591	CcSEcCtD
Alendronate—Abdominal pain—Doxorubicin—pancreatic cancer	0.000336	0.000591	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—SSTR1—pancreatic cancer	0.000335	0.00449	CbGpPWpGaD
Alendronate—Asthenia—Epirubicin—pancreatic cancer	0.00033	0.00058	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—PPY—pancreatic cancer	0.000328	0.0044	CbGpPWpGaD
Alendronate—Pruritus—Epirubicin—pancreatic cancer	0.000325	0.000572	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—SSTR2—pancreatic cancer	0.000322	0.00432	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—JAG2—pancreatic cancer	0.000321	0.00431	CbGpPWpGaD
Alendronate—FDPS—Metabolism—ARG2—pancreatic cancer	0.00032	0.00429	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MEN1—pancreatic cancer	0.000317	0.00425	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SLC2A2—pancreatic cancer	0.000314	0.00422	CbGpPWpGaD
Alendronate—Diarrhoea—Epirubicin—pancreatic cancer	0.000314	0.000553	CcSEcCtD
Alendronate—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000313	0.000551	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—CCKBR—pancreatic cancer	0.000311	0.00417	CbGpPWpGaD
Alendronate—Asthenia—Doxorubicin—pancreatic cancer	0.000305	0.000536	CcSEcCtD
Alendronate—Dizziness—Epirubicin—pancreatic cancer	0.000304	0.000534	CcSEcCtD
Alendronate—ATP6V1A—Disease—SHH—pancreatic cancer	0.000302	0.00405	CbGpPWpGaD
Alendronate—Pruritus—Doxorubicin—pancreatic cancer	0.000301	0.000529	CcSEcCtD
Alendronate—ATP6V1A—Disease—IAPP—pancreatic cancer	0.000298	0.004	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—DTX4—pancreatic cancer	0.000293	0.00392	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GLI1—pancreatic cancer	0.000293	0.00392	CbGpPWpGaD
Alendronate—Vomiting—Epirubicin—pancreatic cancer	0.000292	0.000514	CcSEcCtD
Alendronate—Diarrhoea—Doxorubicin—pancreatic cancer	0.000291	0.000512	CcSEcCtD
Alendronate—Rash—Epirubicin—pancreatic cancer	0.00029	0.000509	CcSEcCtD
Alendronate—Dermatitis—Epirubicin—pancreatic cancer	0.000289	0.000509	CcSEcCtD
Alendronate—Headache—Epirubicin—pancreatic cancer	0.000288	0.000506	CcSEcCtD
Alendronate—ATP6V1A—Disease—HSPA1B—pancreatic cancer	0.000286	0.00384	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NRP1—pancreatic cancer	0.000285	0.00382	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000285	0.00382	CbGpPWpGaD
Alendronate—Dizziness—Doxorubicin—pancreatic cancer	0.000281	0.000494	CcSEcCtD
Alendronate—FDPS—Metabolism—TYMP—pancreatic cancer	0.00028	0.00375	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HEY2—pancreatic cancer	0.000274	0.00367	CbGpPWpGaD
Alendronate—Nausea—Epirubicin—pancreatic cancer	0.000273	0.00048	CcSEcCtD
Alendronate—Vomiting—Doxorubicin—pancreatic cancer	0.00027	0.000475	CcSEcCtD
Alendronate—Rash—Doxorubicin—pancreatic cancer	0.000268	0.000471	CcSEcCtD
Alendronate—Dermatitis—Doxorubicin—pancreatic cancer	0.000268	0.000471	CcSEcCtD
Alendronate—ATP6V1A—Signaling Pathways—GAST—pancreatic cancer	0.000268	0.00359	CbGpPWpGaD
Alendronate—Headache—Doxorubicin—pancreatic cancer	0.000266	0.000468	CcSEcCtD
Alendronate—ATP6V1A—Disease—JAG1—pancreatic cancer	0.000256	0.00344	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SCT—pancreatic cancer	0.000254	0.0034	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HEY1—pancreatic cancer	0.000254	0.0034	CbGpPWpGaD
Alendronate—Nausea—Doxorubicin—pancreatic cancer	0.000252	0.000444	CcSEcCtD
Alendronate—ATP6V1A—Disease—CD44—pancreatic cancer	0.000244	0.00327	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CCK—pancreatic cancer	0.000242	0.00325	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—HSPA1A—pancreatic cancer	0.000242	0.00324	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CNR2—pancreatic cancer	0.000236	0.00316	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GLP1R—pancreatic cancer	0.000236	0.00316	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CCKAR—pancreatic cancer	0.000232	0.00311	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	0.000231	0.0031	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GLP1R—pancreatic cancer	0.000226	0.00302	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—JAG2—pancreatic cancer	0.000225	0.00302	CbGpPWpGaD
Alendronate—FDPS—Metabolism—DPYD—pancreatic cancer	0.000222	0.00297	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MEN1—pancreatic cancer	0.000222	0.00297	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SHH—pancreatic cancer	0.000212	0.00284	CbGpPWpGaD
Alendronate—FDPS—Metabolism—SLC2A2—pancreatic cancer	0.000211	0.00282	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NOTCH4—pancreatic cancer	0.00021	0.00282	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—IAPP—pancreatic cancer	0.000209	0.0028	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	0.000208	0.00279	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	0.000201	0.0027	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PTHLH—pancreatic cancer	0.000201	0.00269	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PTCH1—pancreatic cancer	0.000201	0.00269	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SMAD4—pancreatic cancer	0.000192	0.00258	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—HES1—pancreatic cancer	0.000188	0.00252	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SST—pancreatic cancer	0.000183	0.00246	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	0.000183	0.00246	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—JAG1—pancreatic cancer	0.00018	0.00241	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NOTCH3—pancreatic cancer	0.000179	0.0024	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CNR1—pancreatic cancer	0.000169	0.00227	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—TERT—pancreatic cancer	0.000164	0.00221	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—GCG—pancreatic cancer	0.000163	0.00219	CbGpPWpGaD
Alendronate—FDPS—Metabolism—CD44—pancreatic cancer	0.000163	0.00219	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	0.00016	0.00214	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	0.000158	0.00212	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—HIF1A—pancreatic cancer	0.000157	0.00211	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—TSC2—pancreatic cancer	0.000157	0.0021	CbGpPWpGaD
Alendronate—FDPS—Metabolism—GCG—pancreatic cancer	0.000156	0.0021	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—AGTR1—pancreatic cancer	0.000156	0.00209	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—STK11—pancreatic cancer	0.000154	0.00206	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—APOE—pancreatic cancer	0.000154	0.00206	CbGpPWpGaD
Alendronate—FDPS—Metabolism—STK11—pancreatic cancer	0.000147	0.00197	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NOTCH1—pancreatic cancer	0.000142	0.0019	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	0.000138	0.00185	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—EGF—pancreatic cancer	0.000137	0.00184	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SMAD4—pancreatic cancer	0.000135	0.00181	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HES1—pancreatic cancer	0.000131	0.00176	CbGpPWpGaD
Alendronate—FDPS—Metabolism—TYMS—pancreatic cancer	0.000126	0.0017	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PIK3CD—pancreatic cancer	0.000122	0.00163	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TERT—pancreatic cancer	0.000115	0.00154	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HIF1A—pancreatic cancer	0.00011	0.00148	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TSC2—pancreatic cancer	0.00011	0.00147	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—APOE—pancreatic cancer	0.000108	0.00144	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PIK3CB—pancreatic cancer	0.000106	0.00142	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—KDR—pancreatic cancer	0.000105	0.00141	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PTGS2—pancreatic cancer	0.000105	0.00141	CbGpPWpGaD
Alendronate—FDPS—Metabolism—APOE—pancreatic cancer	0.000103	0.00138	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NFKBIA—pancreatic cancer	0.0001	0.00134	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NOTCH1—pancreatic cancer	9.92e-05	0.00133	CbGpPWpGaD
Alendronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	9.73e-05	0.00131	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PIK3CG—pancreatic cancer	9.71e-05	0.0013	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—EGF—pancreatic cancer	9.59e-05	0.00129	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—CTNNB1—pancreatic cancer	9.42e-05	0.00126	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PIK3CG—pancreatic cancer	9.28e-05	0.00124	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PTEN—pancreatic cancer	9.18e-05	0.00123	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PPARG—pancreatic cancer	8.96e-05	0.0012	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PIK3CD—pancreatic cancer	8.53e-05	0.00114	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—SRC—pancreatic cancer	8.51e-05	0.00114	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—STAT3—pancreatic cancer	8.21e-05	0.0011	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—NRAS—pancreatic cancer	8.19e-05	0.0011	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PIK3CD—pancreatic cancer	8.16e-05	0.00109	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—MYC—pancreatic cancer	7.63e-05	0.00102	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—TGFB1—pancreatic cancer	7.61e-05	0.00102	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—EGFR—pancreatic cancer	7.46e-05	0.001	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PIK3CB—pancreatic cancer	7.44e-05	0.000997	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CXCL8—pancreatic cancer	7.15e-05	0.000958	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PIK3CB—pancreatic cancer	7.11e-05	0.000953	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—KRAS—pancreatic cancer	7.05e-05	0.000945	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PTGS2—pancreatic cancer	7.04e-05	0.000945	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CASP3—pancreatic cancer	6.84e-05	0.000917	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CCND1—pancreatic cancer	6.66e-05	0.000893	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—CTNNB1—pancreatic cancer	6.59e-05	0.000884	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—PIK3CA—pancreatic cancer	6.47e-05	0.000868	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MMP9—pancreatic cancer	6.46e-05	0.000867	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PTEN—pancreatic cancer	6.43e-05	0.000862	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PTEN—pancreatic cancer	6.14e-05	0.000824	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—HRAS—pancreatic cancer	5.99e-05	0.000803	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—SRC—pancreatic cancer	5.96e-05	0.000799	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—VEGFA—pancreatic cancer	5.8e-05	0.000778	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—STAT3—pancreatic cancer	5.75e-05	0.000771	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—NRAS—pancreatic cancer	5.73e-05	0.000769	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—MYC—pancreatic cancer	5.34e-05	0.000716	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TGFB1—pancreatic cancer	5.33e-05	0.000714	CbGpPWpGaD
Alendronate—ATP6V1A—Disease—AKT1—pancreatic cancer	5.29e-05	0.000709	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—EGFR—pancreatic cancer	5.22e-05	0.0007	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—KRAS—pancreatic cancer	4.93e-05	0.000662	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—PIK3CA—pancreatic cancer	4.53e-05	0.000608	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—TP53—pancreatic cancer	4.39e-05	0.000588	CbGpPWpGaD
Alendronate—FDPS—Metabolism—PIK3CA—pancreatic cancer	4.33e-05	0.000581	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—HRAS—pancreatic cancer	4.19e-05	0.000562	CbGpPWpGaD
Alendronate—ATP6V1A—Signaling Pathways—AKT1—pancreatic cancer	3.7e-05	0.000497	CbGpPWpGaD
Alendronate—FDPS—Metabolism—AKT1—pancreatic cancer	3.54e-05	0.000475	CbGpPWpGaD
